From the 2008 News Archive
Governor's New Biotech Initiative to Include Expanded Support for Law School's IP Law Program
Governor Martin O'Malley '88 was joined by University of Maryland School of Law Dean Karen Rothenberg, scientists, and researchers as he unveiled a new vision for the bioscience industry in Maryland at a June 16 event. Under the BIO 2020 Initiative
, the State of Maryland will invest $1.1 billion in Maryland’s bioscience industry over the next 10 years – the largest per capita investment in the biosciences made by any state in the country – to attract and grow biotechnology companies in Maryland. The Governor’s proposal includes $500,000 each year for a decade to support the law school’s Intellectual Property Law Program
"We will expand our efforts to assist with intellectual property valuation and protection services," said Governor O’Malley. "Many start-ups cannot afford professional legal services for intellectual property valuation and protection. This would be an expansion of a successful program at the University of Maryland Law School that works with entrepreneurs to help them validate and protect their intellectual property."
The law school's Intellectual Property Law Program addresses increasingly complex intellectual property law issues and considers these issues from both legal and interdisciplinary perspectives. It is home to the Maryland Intellectual Property Law Resource Center, which was created to educate entrepreneurs, law and business students, and the community about the legal aspects of IP. As part of its mission, the MIPLRC also provides legal services, primarily through a law school student-staffed legal clinic, under the supervision of a licensed patent attorney and affiliated faculty and area specialists. Last year, in an effort to preserve tax credits vital to Maryland’s biotechnology industry, students from the MIPLRC filed an amicus brief in the U.S. Supreme Court case DaimlerChrysler Corp. v. Cuno
"The BIO 2020 Initiative will strengthen Maryland's position as a national and world leader in genetic research," said Dean Rothenberg, founder of the law school's nationally recognized Law & Health Care Program and a member of the Maryland Stem Cell Commission.
During the Spring 2008 semester, the School of Law partnered with the National Human Genome Research Institute to host a national roundtable, "Judging Genes: Implications of the Second Generation of Genetic Tests in the Courtroom."
Posted June 20, 2008 by James Smith